Brief: Sequana Medical Submits Investigational New Drug Application For DSR® 2.0

Sequana Medical NV

03/04/2023 06:09

April 3 (Reuters) - Sequana Medical NV  SEQUA.BR :
    * SEQUANA MEDICAL ANNOUNCES SUBMISSION OF INVESTIGATIONAL
NEW DRUG
(IND) APPLICATION FOR DSR® 2.0 FOR TREATMENT OF CONGESTIVE HEART
FAILURE
    * CLEARANCE OF IND WILL PAVE WAY FOR COMPANY TO INITIATE ITS
RANDOMIZED CONTROLLED PHASE 1/2A MOJAVE STUDY IN US, PLANNED FOR
Q2 2023

Source text for Eikon:  ID:nGNE46VRMS 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))